Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001827584-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-23 | 2023-03-21+ | TARS | Neervannan Seshadri | COO | S - Sale | $12.55 | -1,141 | 55.5K | -2% | -$14.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | S | D | 379 | $12.64 | 55,086 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-23 | S | D | 390 | $12.15 | 54,696 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-21 | S | D | 372 | $12.89 | 55,465 | D | — | — |